ArticleDiabetes & metabolism journal2025
Study Design and Protocol for a Randomized Controlled Trial of Enavogliflozin to Evaluate Cardiorenal Outcomes in Type 2 Diabetes (ENVELOP).
Nam Hoon Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.